A scaleable synthesis of fiduxosin
AR Haight, AE Bailey, WS Baker, MH Cain…
Index: Haight, Anthony R.; Bailey, Anne E.; Baker, William S.; Cain, Michael H.; Copp, Richard R.; Demattei, John A.; Ford, Kelley L.; Henry, Rodger F.; Hsu, Margaret C.; Keyes, Robert F.; King, Steven A.; McLaughlin, Maureen A.; Melcher, Laura M.; Nadler, William R.; Oliver, Patricia A.; Parekh, Shyamal I.; Patel, Hemant H.; Seif, Louis S.; Staeger, Mike A.; Wayne, Gregory S.; Wittenberger, Steven J.; Zhang, Weijiang Organic Process Research and Development, 2004 , vol. 8, # 6 p. 897 - 902
Full Text: HTML
Citation Number: 39
Abstract
Fiduxosin (1) has been under development at Abbott Laboratories for the treatment of benign prostatic hyperplasia. A convergent strategy required methodologies for preparation of an enantiomerically pure 3, 4-cis-disubstituted pyrrolidine and a 2, 3, 5-trisubstituted thienopyrazine in a regiospecific manner. A [3+ 2] cycloaddition of an enantiopure azomethine ylide followed by a diastereoselective crystallization was employed to prepare ...
Related Articles:
[Wu, Xiaofeng; Liu, Jianke; Li, Xiaohong; Zanotti-Gerosa, Antonio; Hancock, Fred; Vinci, Daniele; Ruan, Jiwu; Xiao, Jianliang Angewandte Chemie - International Edition, 2006 , vol. 45, # 40 p. 6718 - 6722]
[Forrester; Jones; Newton; Preston Tetrahedron, 2001 , vol. 57, # 14 p. 2871 - 2884]
[Tsuchida, Eishun; Hasegawa, Etsuo; Komatsu, Teruyuki; Nakata, Taisaku; Nishide, Hiroyuki Chemistry Letters, 1990 , # 3 p. 389 - 392]
[Meyers; Shimano Tetrahedron Letters, 1993 , vol. 34, # 31 p. 4893 - 4896]